Companies

See how salaries can vary from company to company

Gevo, Inc., a renewable chemicals and low-carbon fuel company, focuses on the development and commercialization of renewable alternatives to petroleum-based products in the United States. It operates through two segments, Gevo, Inc. and Gevo Development/Agri-Energy. The company engages in the research, development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of renewable jet and other fuels; and retrofit process of chemicals and biofuels. It is also involved in the production of ethanol, isobutanol, and related products. In addition, the compa... view company details

John H. Northrop & Associates, Inc. (JHNA) is a technical consulting firm serving the defense industry since 2001. Privately owned and headquartered in Clifton, VA, JHNA is a Service-Disabled Veteran-Owned Small Business (SDVOSB). We specialize in providing warfighter to engineer interface. Our employees are former military leaders with both operational experience and engineering and technical expertise. We help our customers navigate the systems engineering and acquisition process to ensure that capabilities under development respond to warfighting needs. JHNA has domain expertise in Army avi... view company details

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that is in Phase III clinical trials for the treatment of type 1 and type 2 diabetes; LX9211, which is in Phase Ib clinical development for the treatment of neuropathic pain; and LX276... view company details

LCRA provides many vital services to Texans, including delivering electricity, managing the water supply and environment of the lower Colorado River basin, providing public recreation areas, and supporting community development. view company details

Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas. Its drug development services include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and... view company details

Madwell is a Brooklyn-based creative agency that specializes in strategy, design, development, branding, and comprehensive ideation. Analytics, data, and technology are as much a part of our DNA as a collective, uncontrollable urge to make things beautiful. view company details

Mendix, a subsidiary of Siemens, offers a low-code application development platform that lets programming-inexperienced individuals and businesses build, test, deploy, and iterate on-premise or cloud-based applications. view company details

Norris Square Community Alliance (formerly Norris Square Civic Association) is a community development corporation founded in 1983 by a group of community women who desired to take control of their neighborhood and provide a healthy and safe environment for their children. view company details

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other medical conditions. The company's development stage drug candidates for cardiosphere-derived cells include CAP-1002 that completed phase I/II clinical trial in subjects with DMD; phase I clinical trial for treating heart failure; and phase I/II clinical trial in subjects with myocardial infarction. It is also developing CAP-2003 that is in pre-clinical development ... view company details

Enanta Pharmaceuticals, Inc., a biotechnology company, focuses on the research and development of small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, primary biliary cholangitis, and hepatitis B virus. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of c... view company details

Harbor Diversified, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of products for the treatment of diseases related to aging. The company primarily focuses on the development of a series of steroid hormone analogs that are derived from the human adrenal metabolome. Its development-stage product candidates that have completed Phase I/IIa clinical trials include Apoptone (HE3235) for use in patients with late-stage prostate cancer; and Triolex (HE3286) used in obese type 2 diabetes mellitus patients. The company was formerly known as Harbor BioSciences, ... view company details

A National Association member of the U.S. Soccer Federation, US Club Soccer is an organization committed to the development and support of soccer clubs in the United States. US Club Soccer offers youth and adult registration, league- and cup-based competition platforms at the recreational and competitive levels, as well as a variety of other programming, including the Olympic Development Program-sanctioned id2 Program and Player Development Programs. Through US Club Soccer, all of a club's programs - recreational, competitive and adult - are able to be united under one organizational umbrella,... view company details

Xenetic Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer. Its proprietary drug development platform, PolyXen, enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The company has a research, development, license, and supply agreements wit... view company details

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is Annamycin that is in Phase I/II clinical trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) in the United States and Poland. The company's flagship immune/transcription modulator is WP1066, a STAT3 inhibitor, which is in Phase I clinical trial for the treatment of brain tumor, as well as to treat pancreatic cancer, AML, and glioblastoma. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneou... view company details

A Full Spectrum of Housing Services Under One Roof Whether you're looking for professional property management, construction management services, new project financing, or a joint venture development partner, The John Stewart Company can guide you through the complex process of multi-family real estate financing, development, marketing and management. We have the versatility and professional capacity to perform every task from initial feasibility through development and long-term property management. We serve our customers with 1,000 employees in five offices across California. Our management ... view company details

Soliant Consulting® is a consulting and development partner for custom software applications. We help clients anticipate the future of their businesses and build powerful digital solutions to keep them ahead of the game. As consultants, we concentrate on what to build and why, and our seasoned project managers ensure clients understand our process every step of the way. We empower them through digital transformation strategies, legacy system modernization, web portal development, and custom software architecture. Through our role as a Salesforce Partner, we help clients increase their return o... view company details

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923 candidate, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial for treating patients with interstitial lung diseases (ILDs), such as pulmonary sarcoidosis; and in Phase 1 clinical trial to treat chronic hypersensitivity pneumonitis and connective tissue disease ILD. The company has a colla... view company details

BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX or Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, and human lipoma, as well as uterine fibroids. In addition, the company engages in the development of other clinic... view company details

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery system for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase IIB clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; that has completed Phase IIa clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary di... view company details

BAO Systems is an industry leader in digital data solutions for health and development. We empower our partners to implement scalable and sustainable solutions that uncover data-driven insights to improve livelihoods, strengthen health systems, and achieve equitable human development. Our team is comprised of passionate public health and development practitioners, information system experts, software engineers, system engineers, monitoring and evaluation advisors, and data scientists. Our team excels in providing a broad spectrum of solutions around data collection, management, integration and... view company details